Gene · 273
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature. | Gynecol Oncol Rep | 2023 | 36703705 | PubTator, text mining | PubMed |
| Anti-IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature. | Mov Disord Clin Pract | 2023 | 36698996 | PubTator, text mining | PubMed |
| Identification of mosquito proteins that differentially interact with alphavirus nonstructural protein 3, a determinant of vector specificity. | PLoS Negl Trop Dis | 2023 | 36696390 | PubTator, text mining | PubMed |
| Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes. | Drugs | 2023 | 36696027 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment. | Brain Sci | 2023 | 36672107 | PubTator, text mining | PubMed |
| Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. | Brain Behav Immun | 2023 | 36657623 | PubTator, text mining | PubMed |
| Spontaneously Resolving Encephalitis in Children with Acute COVID Infection. | Indian J Pediatr | 2023 | 36639592 | PubTator, text mining | PubMed |
| AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies. | J Neuroimmunol | 2023 | 36608398 | PubTator, text mining | PubMed |
| Neoantigens: promising targets for cancer therapy. | Signal Transduct Target Ther | 2023 | 36604431 | PubTator, text mining | PubMed |
| Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report. | BMC Neurol | 2023 | 36597054 | PubTator, text mining | PubMed |
| Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature. | J Clin Neurosci | 2023 | 36586226 | PubTator, text mining | PubMed |
| A SNX1-SNX2-VAPB partnership regulates endosomal membrane rewiring in response to nutritional stress. | Life Sci Alliance | 2023 | 36585258 | PubTator, text mining | PubMed |
| A rare case of a wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with cutaneous lupus erythematosus after COVID-19 infection. | J Neurol | 2023 | 36576573 | PubTator, text mining | PubMed |
| Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review. | J Neural Transm (Vienna) | 2023 | 36576564 | PubTator, text mining | PubMed |
| Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome. | Gut Microbes | 2023 | 36576106 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin. | Biol Psychiatry | 2023 | 36481066 | PubTator, text mining | PubMed |
| Sleep disorders and polysomnography findings in patients with autoimmune encephalitis. | Neurol Sci | 2023 | 36454441 | PubTator, text mining | PubMed |
| GTP-stimulated membrane fission by the N-BAR protein AMPH-1. | Traffic | 2023 | 36435193 | PubTator, text mining | PubMed |
| Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects. | Brain Behav Immun | 2023 | 36323361 | PubTator, text mining | PubMed |
| Anti-IgLON5 disease: a novel topic beyond neuroimmunology. | Neural Regen Res | 2023 | 36254983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/273/papers?page=17